| abstract |
Disclosed is a medicament combination comprising 6-hydroxy-8-{1-hydroxy-2-[2-(4-methoxy-phenyl)-1,1-dimethyl-ethylamino]-ethyl}-4Hbenzo[1,4]oxazin-3-one (1.1), and a tiotropium salt (2.1), where the molar ratio of the active substances 1.1 to 2.1 is in the range from 1:1 to 10:1. Also disclosed is the use of the above combination for treating inflammatory and obstructive respiratory complaints, for inhibiting premature labour in midwifery (tocolysis), for restoring sinus rhythm in the heart in atrioventricular block, for correcting bradycardic heart rhythm disorders (antiarrhythmic), for treating circulatory shock (vasodilatation and increasing the heart volume) as well as for the treatment of skin irritations and inflammation. |